Arcadia Investment Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115K Hold
1,155
0.02% 134
2025
Q4
$141K Hold
1,155
0.02% 130
2025
Q3
$130K Hold
1,155
0.02% 139
2025
Q2
$155K Hold
1,155
0.02% 133
2025
Q1
$77.7K Hold
1,155
0.01% 179
2024
Q4
$72K Buy
+1,155
New +$108K 0.01% 191
2024
Q3
Sell
-738
Closed -$111K 319
2024
Q2
$111K Sell
738
-369
-33% -$44.3K 0.02% 151
2024
Q1
$81.9K Sell
1,107
-4
-0.4% -$330 0.01% 170
2023
Q4
$87.6K Sell
1,111
-3,750
-77% -$226K 0.02% 174
2023
Q3
$266K Buy
4,861
+83
+2% +$5.97K 0.06% 115
2023
Q2
$401K Sell
4,778
-149
-3% -$11.4K 0.08% 93
2023
Q1
$373K Buy
4,927
+1,338
+37% +$92.5K 0.08% 97
2022
Q4
$222K Buy
+3,589
New +$191K 0.05% 122

Other funds holding TMDX

Arcadia Investment Management's TMDX Position: Q1 2026 in Review

Arcadia Investment Management held its Transmedics (TMDX) position steady in Q1 2026 at 1,155 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #134.

Arcadia Investment Management first reported a position in TMDX in Q4 2022 and has held it in 13 quarters since. The position peaked at $401K in Q2 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Arcadia Investment Management held 1,155 shares of Transmedics worth $115K as of Q1 2026.
  • Arcadia Investment Management left its Transmedics share count unchanged in Q1 2026.
  • Transmedics made up 0.02% of Arcadia Investment Management's portfolio in Q1 2026, its #134 holding.
  • Arcadia Investment Management first reported a position in Transmedics in Q4 2022 and has held it in 13 quarters since.
  • Arcadia Investment Management's Transmedics position peaked at $401K in Q2 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.